Sentences with phrase «leading cancer care»

PetCure Oncology commits unconditionally to delivering industry - leading cancer care to pets and unyielding support to the families that love them.

Not exact matches

When three researchers asked 12 breast cancer patients from central Mexico, for instance, what each did right after discovering a lump in her breast, the women's answers revealed a dozen different health care routes — paths that led, in some cases, to markedly different outcomes.

About MaRS Innovation MaRS Innovation is the commercialization agent for Ontario's exceptional discovery pipeline from 15 leading academic institutions, including Baycrest Centre for Geriatric Care, Centre for Addiction and Mental Health, Holland Bloorview Kids Rehabilitation Hospital, The Hospital for Sick Children (SickKids), MaRS Discovery District, Mount Sinai Hospital, Ontario Institute for Cancer Research, St. Michael's Hospital, Ryerson University, Sunnybrook Health Sciences Centre, Thunder Bay Regional Research Institute, University Health Network, University of Toronto, Women's College Hospital and York University.

Breast Cancer Care, the leading breast cancer support and information charity in the UK, has produced a new report, backed by Age UK, that makes clear recommendations to improve outcomes and experiences for older women with breast cancer, a demographic proven to have poorer relative survival rates and an increased likelihood of presenting later with symptoms and of receiving non-standard treatCancer Care, the leading breast cancer support and information charity in the UK, has produced a new report, backed by Age UK, that makes clear recommendations to improve outcomes and experiences for older women with breast cancer, a demographic proven to have poorer relative survival rates and an increased likelihood of presenting later with symptoms and of receiving non-standard treatcancer support and information charity in the UK, has produced a new report, backed by Age UK, that makes clear recommendations to improve outcomes and experiences for older women with breast cancer, a demographic proven to have poorer relative survival rates and an increased likelihood of presenting later with symptoms and of receiving non-standard treatcancer, a demographic proven to have poorer relative survival rates and an increased likelihood of presenting later with symptoms and of receiving non-standard treatments.

Previous results from the trial have already changed clinical practice — data released last year has led to docetaxel chemotherapy now being part of the standard of care for many men with prostate cancer.

Extensive studies have found that 20 % to 30 % of breast cancers are characterized by over-expression of HER2, which makes the cancer cells grow and divide faster, leading to a cancer that's more aggressive and more likely to be resistant to the standard of care.

To ensure that patients can receive all recommended care, we need to recognize the financial burden of cancer and identify patients at risk for financial concerns,» says lead study author Christine M. Veenstra, M.D., M.S.H.P., clinical lecturer in hematology / oncology at the University of Michigan Medical School.

«However, unlike smoking, which substantially increases the likelihood of premature death (for example, mortality from lung cancer), obesity and associated Type 2 diabetes primarily lead to long - term disability, so that from a lifetime perspective, obesity could tax the health care system even more than smoking.»

Patient navigation, or the linking of a newly diagnosed cancer patient with a professional trained in assisting patients though the complex journey of cancer diagnosis and treatment, may lead to better breast cancer care in high risk and minority women.

Last summer, Biden launched the Biden Cancer Initiative along with his wife Dr. Jill Biden to continue, outside the federal government, an effort he has led since 2016 to speed advances in cancer research andCancer Initiative along with his wife Dr. Jill Biden to continue, outside the federal government, an effort he has led since 2016 to speed advances in cancer research andcancer research and care.

«The compelling results seen in this global study provide unequivocal evidence supporting the clinical utility of Oncotype DX to risk - stratify patients with early stage breast cancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medcancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of MedCancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medicine.

Dr. Cooper joined MDACC in 2006 as section chief of cell therapy at the Children's Cancer Hospital, where he cared for children undergoing bone marrow transplantation and led scientific efforts to develop new treatment approaches that pair genetic engineering with immunotherapies.

«This is the first national study to identify specific regions of the United States where residents may be at an increased risk for poor clinical outcomes — including misdiagnoses and late detection — as a result of limited access to specialized gynecologic cancer care,» says David Shalowitz, MD, a fellow in the division of Gynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author on the study.

Though there may be many reasons why patients would not receive surgical interventions — including extensive disease or other significant health problems — the authors say further study of these cases could help identify barriers and lead to interventions specifically aimed at addressing disparities in cancer care delivery.

«The focus of chemotherapy and existing standard - of - care is on killing cancer cells but instead we took a completely different approach which changes the environment the cancer cells live in,» said Mick Bhatia, director and senior scientist with the McMaster Stem Cell and Cancer Research Institute, who led the group that performed the cancer cells but instead we took a completely different approach which changes the environment the cancer cells live in,» said Mick Bhatia, director and senior scientist with the McMaster Stem Cell and Cancer Research Institute, who led the group that performed the cancer cells live in,» said Mick Bhatia, director and senior scientist with the McMaster Stem Cell and Cancer Research Institute, who led the group that performed the Cancer Research Institute, who led the group that performed the study.

It's the first CAR - T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

«The integration of palliative care, as a necessary and essential component of cancer care, is one that has been increasingly endorsed,» said Richard Riedel, M.D., lead author of the Duke study and medical director of Duke University Hospital's solid tumor inpatient service.

Cherny said: «Together these publications help patients with advanced and incurable cancer ask appropriate questions and have meaningful discussions with their oncologist that lead to coordinated and holistic care.

Once tests and exams come back indicating cancer, says David S. Parda, MD, FACP, past president of the Pennsylvania Society of Oncology & Hematology, it's time for the patient and her physician - led health care team to come up with a plan to fight it.

The findings, published online today in the leading medical journal The Lancet, demonstrate the benefits of cancer centres providing early specialized palliative care in outpatient clinics, says principal investigator Dr. Camilla Zimmermann, Head, Palliative Care Program, UHN, and Medical Director, Al Hertz Centre for Supportive and Palliative Care at the Princess Margacare in outpatient clinics, says principal investigator Dr. Camilla Zimmermann, Head, Palliative Care Program, UHN, and Medical Director, Al Hertz Centre for Supportive and Palliative Care at the Princess MargaCare Program, UHN, and Medical Director, Al Hertz Centre for Supportive and Palliative Care at the Princess MargaCare at the Princess Margaret.

The research team is led by Carl June, MD, the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine and director of Translational Research in the Abramson Cancer Center, along with David Porter, MD, the Jodi Fisher Horowitz Professor in Leukemia Care Excellence and director of Blood and Marrow Transplantation in the Abramson Cancer Center.

«These findings clearly point to the very important role that health care providers can play in increasing coverage with this safe and effective vaccine,» said lead author Linda M. Niccolai, Ph.D., associate professor in the school's Department of Epidemiology of Microbial Diseases and member of the Cancer Prevention and Control Program of the Yale Cancer Center.

This new cancer panel has the potential to significantly enhance patient care while greatly reducing the cost to the healthcare system,» said study lead - author Howard B. Urnovitz, Ph.D., Chief Executive Officer of Chronix Biomedical.

«Early on, we began to suspect that methylnaltrexone might inhibit cancer growth» said Jonathan Moss, MD, PhD, lead author of the study and professor of anesthesia and critical care at the University of Chicago.

Should the results of this study be repeated in the larger Phase III trial, it would lead to a new standard of care for kidney cancer patients, said Dr. Hammers, formerly of Johns Hopkins medical system, who holds the Eugene P. Frenkel, M.D. Scholar in Clinical Medicine at UT Southwestern.

For the new study, investigators led by Helmneh Sineshaw, M.D., MPH, at the American Cancer Society with collaborators from Dana - Farber Cancer Institute at Harvard Medical School, focused on the impact of access to care on black - white survival disparity.

«We already know that coordinated, patient - centered palliative care improves care quality, enhances survival, and reduces costs for persons with cancer,» said R. Sean Morrison, MD, Director of the National Palliative Care Research Center and Professor of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai and lead author of the stcare improves care quality, enhances survival, and reduces costs for persons with cancer,» said R. Sean Morrison, MD, Director of the National Palliative Care Research Center and Professor of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai and lead author of the stcare quality, enhances survival, and reduces costs for persons with cancer,» said R. Sean Morrison, MD, Director of the National Palliative Care Research Center and Professor of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai and lead author of the stCare Research Center and Professor of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai and lead author of the study.

Patients with incurable cancer and numerous other serious health conditions who consulted with a palliative care team within two days of hospitalization had significant savings in hospital costs, according to a new study led by researchers at the Icahn School of Medicine at Mount Sinai.

Leading scientist Professor Alan Ashworth has received a Lifetime Achievement Award from the European Society for Medical Oncology (ESMO) in recognition of his work to improve the care of people with breast cancer.

The findings may lead to new and better ways to diagnose and care for people with familial cancer.

The research ideas you develop at the workshop should: • Lead to the significant advancement of our understanding of sensor technologies suitable for liquid biopsy • Consider the practical challenges of low volume liquid usually taken for analysis and the inconsistency of sample preparation across point of care sites • Prioritise biomarkers with high specificity for cancer or even for multiple cancer types, including markers specific to cancers that will become aggressive as opposed to non-lethal disease

The Cancer Research Institute (CRI), established in 1953, is the world's leading nonprofit organization dedicated exclusively to transforming cancer patient care by advancing scientific efforts to develop new and effective immune system - based strategies to prevent, diagnose, treat, and eventually cure all caCancer Research Institute (CRI), established in 1953, is the world's leading nonprofit organization dedicated exclusively to transforming cancer patient care by advancing scientific efforts to develop new and effective immune system - based strategies to prevent, diagnose, treat, and eventually cure all cacancer patient care by advancing scientific efforts to develop new and effective immune system - based strategies to prevent, diagnose, treat, and eventually cure all cancers.

About the Dana - Farber Cancer Institute Dana - Farber Cancer Institute (www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United SCancer Institute Dana - Farber Cancer Institute (www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United SCancer Institute (www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United Scancer research and care centers in the United States.

For those care providers interested in learning more about long - term care of cancer survivors, Fred Hutch organizes conferences and continuing education courses led by local experts.

Kessler is proud to be part of one only nine federally - designated Model Systems for the treatment and research of both spinal cord and brain injuries, a distinction shared with Kessler Foundation, and also leads the field in the care of individuals with stroke, neurologic diseases, amputation, orthopedic trauma, cancer and cardiac conditions.

She gave one example of how her genetics and genomic medicine research has been translated to personalizing cancer patient care, and described what the Cleveland Clinic is doing in leading the charge in personalizing healthcare.

As the fundraising partner of the BC Cancer Agency and the largest charitable funder of cancer research in this province, we enable donors to make contributions to leading - edge research that have a direct impact on improvements to cancer care for patients in British ColCancer Agency and the largest charitable funder of cancer research in this province, we enable donors to make contributions to leading - edge research that have a direct impact on improvements to cancer care for patients in British Colcancer research in this province, we enable donors to make contributions to leading - edge research that have a direct impact on improvements to cancer care for patients in British Colcancer care for patients in British Columbia.

Led by an inter-disciplinary team of scientists and clinicians, the Center holds the promise to significantly change the bleak statistics associated with this disease by revolutionizing pancreatic cancer care.

About The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer - free world by integrating scientific research with excellence in education and patient - centered care, a strategy that leads to better methods of prevention, detection and treaCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer - free world by integrating scientific research with excellence in education and patient - centered care, a strategy that leads to better methods of prevention, detection and treaCancer Hospital and Richard J. Solove Research Institute The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer - free world by integrating scientific research with excellence in education and patient - centered care, a strategy that leads to better methods of prevention, detection and treaCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer - free world by integrating scientific research with excellence in education and patient - centered care, a strategy that leads to better methods of prevention, detection and treaCancer Hospital and Richard J. Solove Research Institute strives to create a cancer - free world by integrating scientific research with excellence in education and patient - centered care, a strategy that leads to better methods of prevention, detection and treacancer - free world by integrating scientific research with excellence in education and patient - centered care, a strategy that leads to better methods of prevention, detection and treatment.

«Our study may, we hope, lead to improvements in the care of newly diagnosed cancer patients and hopefully diminish the risk of stress - related disease and death,» says Dr Fang Fang.

As a cancer center that combines patient care and research, Hollings brings together over 180 physicians and scientists who are driving the discoveries that will lead to tomorrow's treatments.

Staffed by some of the world's leading experts in the field, the Ludwig Center for Cancer Immunotherapy is streamlining the translation of basic science discoveries made in a variety of cancers toward patient care.

We're a member of the National Comprehensive Cancer Network along with 27 other leading centers working together to improve quality and effectiveness of cancerCancer Network along with 27 other leading centers working together to improve quality and effectiveness of cancercancer care.

As one of the leading cancer treatment centers in the Southeast, Hollings Cancer Center combines the full range of cancer specialties to deliver a higher level of care to the patients we cancer treatment centers in the Southeast, Hollings Cancer Center combines the full range of cancer specialties to deliver a higher level of care to the patients we Cancer Center combines the full range of cancer specialties to deliver a higher level of care to the patients we cancer specialties to deliver a higher level of care to the patients we serve.

A study led by Dr. Leena Gandhi suggests immunotherapy should be the new standard of care to treat lung cancer.

The resulting affirmation from physicians, care providers, educators and scientists led to funding for implementation from the Georgia Cancer Coalition, the Georgia Society of Clinical Oncology, the Oncology Nursing Society, Siemens Medical Solutions, and the Schools of Medicine at Emory, the Medical College of Georgia and Mercer University.

With more than 30,000 members, ASCO is the world's leading professional organization representing physicians who care for people with cancer.

UT Southwestern's cancer care earned High Performing recognition in U.S. News & World Report for 2017 — 18, placing us among the country's leading cancer treatment facilities.

Amid the complex system of American health care, where progress has lagged in the prevention and early detection of cancer, a major public health project is underway in San Francisco with one ambitious goal: reducing cancer in the city where the disease is the leading cause of death.

It reflects our promise — and ability — to deliver the best cancer care available today and discover new treatments that will lead to the best cancer care of tomorrow.